Sort
23,748 grants matching “melanoma”
TUMOR-TARGETING WITH NEW BORONATED PORPHYRINS
$198,450Louisiana State Univ A&M Col Baton Rouge · R01 · FY2005 · CA
Prognostic Significance of Neuronal Differentiation of Cutaneous Melanoma
$198,450Vijayasaradhi Setaluri · University Of Wisconsin-Madison · R21 · FY2008 · CA
TUMOR-TARGETING WITH NEW BORONATED PORPHYRINS
$198,450Louisiana State Univ A&M Col Baton Rouge · R01 · FY2004 · CA
Improving Lytic Potency of Herpes Virus Cancer Therapeutics
$198,360Pin Yi Wang · Research Inst Nationwide Children'S Hosp · R21 · FY2019 · CA
SOMATIC NON-SYNONYMOUS MUTATIONS AS UNIQUE TUMOR ANTIGENS IN MELANOMA
$198,360Beatriz M. Carreno · Washington University · R21 · FY2013 · CA
Host Cell Assisted Primary and Metastatic Tumor Regrowth after Chemotherapy
$198,294Robert S Kerbel · Sunnybrook & Women'S Coll Hlth Scis Ctr · R01 · FY2010 · CA
Host Cell Assisted Primary and Metastatic Tumor Regrowth after Chemotherapy
$198,294Robert S Kerbel · Sunnybrook & Women'S Coll Hlth Scis Ctr · R01 · FY2009 · CA
In-Clinic Latanoprost As a Novel Vaccine Adjuvant
$198,230Zhaoyang You · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · AI
CANCER AND LEUKEMIA GROUP B
$198,198Duke University · U10 · FY2001 · CA
Genome amplification and dysbiosis in tongue cancer
$198,125Donna G Albertson · New York University · R21 · FY2017 · DE
Metabolic adaptations in melanoma brain metastasis
$198,103Eva Hernando · New York University School Of Medicine · R21 · FY2024 · CA
A germline variant that predicts and modulates the response of melanoma to immunotherapy
$198,103Iman Osman · New York University School Of Medicine · R21 · FY2017 · CA
Tetraacylated lipid A enhancement of checkpoint blocking cancer immunotherapy
$198,103Dennis L. Kasper · Harvard Medical School · R21 · FY2025 · CA
DISSECTING THE ROLE OF THE IMMUNE MICROENVIRONMENT IN MELANOMA BONE METASTASIS
$198,103Eva Hernando · New York University School Of Medicine · R21 · FY2025 · CA
Administrative Core
$198,101John H Sampson · Duke University · P50 · FY2016 · CA
Mitf: A Master Gene for Melanocyte Development
$198,022David E Fisher · Massachusetts General Hospital · R01 · FY2008 · AR
Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites
$198,018Matthew Everett Griffin · University Of California-Irvine · K22 · FY2023 · CA
Project 1: TLR4 as a Novel Target for Skin Cancer Prevention
$197,988Georg T Wondrak · University Of Arizona · P01 · FY2021 · CA
Targeting of mTOR Activity for Chemoprevention of Solar UV-induced Skin Cancer
$197,855Timothy Bowden · University Of Arizona · P01 · FY2015 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$197,804University Of Pretoria · U10 · FY2002 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$197,804University Of Pretoria · U10 · FY2003 · CA
Human Monoclonal Antibodies from Immunized Patient Lymphocytes
$197,764Philip O. Livingston · Mabvax Therapeutics, Inc. · R41 · FY2008 · CA
Prevention of Melanoma by Targeting Tyrosinase with Dietary Quercetin
$197,708Randy Burd · University Of Arizona · R21 · FY2012 · CA
CELLULAR PROTEIN MATURATION AND DEGRADATION
$197,695University Of Massachusetts Amherst · R01 · FY2002 · CA
Human Immunology Core
$197,677Eline Tjetske Luning Prak · University Of Pennsylvania · P30 · FY2017 · CA